Pharmaceutical

Lava signs collaboration agreement with MSD for prostat...

MSD will supply Keytruda to be evaluated as a combination treatment with Lava’s ...

Repare bags $40m from Roche as solid tumour trial begins

The milestone-based payment came from Roche after Repare dosed the first patient...

Gilead’s Tecartus escapes harsher classwide boxed warni...

The US FDA has requested a different safety label for Gilead’s Tecartus compared...

What is the UK’s Covid-19 drug armoury like amid rising...

As a new variant spearheads a winter spike in Covid-19 infections in the UK, the...

STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to ...

As it expands its pipeline of inflammation-targeting drugs, Sanofi said Tuesday ...

STAT+: When it comes to policing pharma, the FTC says i...

The FTC has attempted to crack down on the pharma industry over concerns that dr...

STAT+: Osteoarthritis might be linked to protein known ...

Researchers looking into the cause of osteoarthritis were surprised to find of a...

New chronic Covid study offers insight into which immun...

A new study analyzes how long it took for people with different levels of immune...

STAT+: Pharmalittle: We’re reading about Lilly’s gene t...

The U.K. hopes to secure a major new vaccines investment by AstraZeneca with a p...

Lilly’s gene therapy restores hearing in an 11-year-old...

Want to stay on top of the science and politics driving biotech today? Sign up t...

As NIH grant runs out, Dog Aging Project founders look ...

The project — a beacon of hope for human longevity research — has been studying ...

Opinion: Defunding liberal arts is dangerous for health...

Defunding liberal arts is dangerous for health care.

STAT+: FDA OKs — but doesn’t require — a non-cancer-cau...

Medical device manufacturers can now more easily use a chemical that doesn't cau...

Opinion: After 20 years in rehabilitation research, my ...

After 20 years of work in rehabilitation research, my young daughter’s traumatic...

STAT+: A for-profit health system’s financial issues co...

Steward Health Care, which runs nine Massachusetts hospitals, is in such grave f...

Ahead of Medicare drug price reform, pharma’s drug pric...

Want to stay on top of the science and politics driving biotech today? Sign up t...